Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Breast Neoplasms 3Cardiovascular Diseases 2Metabolic Syndrome 1Cardiotoxicity 1Breast Diseases 1

Interventions

palbociclib 2Blood Pressure 2xinmailong 1ribociclib 1abemaciclib 1Vitamin D 1Social Determinants of Health 1Rivaroxaban 1Restraint, Physical 1Raloxifene Hydrochloride 1Quality of Life 1Progestins 1Progesterone 1Positron-Emission Tomography 1Patient Navigation 1Linseed Oil 1Hormone Replacement Therapy 1High-Intensity Interval Training 1Heart Rate 1Heart Function Tests 1Genetic Testing 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Anthracyclines 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Blood Pressure × Breast × Clear all
NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT02652975 2019-10-09

ABCDE

University of Aarhus

Phase NA Completed
76 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡